Balanced news tone
News Sentiment
BMY sentiment intelligence
Bristol-Myers Squibb Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
56
Balanced news tone
39 relevant articles
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-5.5% over one week, -9.2% over four weeks, trend inactive, and near fair-value range.
3 Reasons to Buy Bristol Myers Squibb Stock
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
78/100 classification
One-week reaction
-5.5%
Price reacting lower
Trend fit
Trend inactive
-9.2% over four weeks
Fair value
9.9%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
14
Neutral
22
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Bristol Myers Squibb (BMY) Margin Strength In Q1 2026 Challenges Bearish Earnings Narratives
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 02 May 2026 07:00
- Source
- simplywall.st
TradingKey
Direct company coverage
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.18% on May 1: Drivers Behind the Movement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- TradingKey
Morningstar
Direct company coverage
Bristol-Myers Squibb Earnings: Steady Quarter Ahead of Multiple Late-Stage Readouts
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Morningstar
IndexBox
Direct company coverage
Bristol Myers Squibb: Value Stock Analysis for Dividend Investors in 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 13 Apr 2026 07:00
- Source
- IndexBox
StockStory
Direct company coverage
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- StockStory
simplywall.st
Direct company coverage
Should You Buy Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend?
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 30 Mar 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Is Bristol-Myers Squibb Company (BMY) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Mar 2026 07:00
- Source
- Market source
StockStory
Direct company coverage
Why Bristol-Myers Squibb (BMY) Stock Is Up Today
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2026 07:00
- Source
- StockStory
simplywall.st
Direct company coverage
We Like Bristol-Myers Squibb's (NYSE:BMY) Earnings For More Than Just Statutory Profit
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 18 Feb 2026 08:00
- Source
- simplywall.st